https://cancerdiscoveries.com/discoveries/tardigrade-inspired-mrna-strategy-protects-healthy-tissue-during-radiation-in-mice/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/randomized-trial-finds-ai-supported-mammography-increased-cancer-detection-while-reducing-reading-workload/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/single-glioblastoma-case-leads-to-phase-ii-test-of-neoadjuvant-checkpoint-immunotherapy/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/gata6-study-identifies-a-colorectal-cancer-growth-mechanism-in-cells-and-mice/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/bnt116-lung-cancer-vaccine-remains-under-study-in-first-in-human-trial/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/kras-circulating-tumor-dna-linked-to-metastasis-and-survival-in-pancreatic-cancer/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/18-gene-urine-test-improves-detection-of-higher-grade-prostate-cancer-in-validation-studies/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/dostarlimab-produces-sustained-complete-responses-in-dmmr-rectal-cancer-study/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/personalized-rna-vaccine-produces-durable-t-cell-responses-in-pancreatic-cancer-study/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-expands-enhertu-use-to-hr-positive-her2-low-and-her2-ultralow-metastatic-breast-cancer/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-approves-durvalumab-as-consolidation-therapy-for-limited-stage-small-cell-lung-cancer/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/pt217-an-investigational-dll3-cd47-bispecific-antibody-remains-under-first-in-human-study-for-neuroendocrine-cancers/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-approves-inavolisib-combination-for-pik3ca-mutated-endocrine-resistant-hr-positive-breast-cancer/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-approves-vorasidenib-for-idh1-idh2-mutant-grade-2-glioma/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-grants-accelerated-approval-to-afamitresgene-autoleucel-an-engineered-cell-therapy-for-synovial-sarcoma/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/lunresertib-plus-camonsertib-produces-durable-responses-in-advanced-endometrial-and-ovarian-cancer-in-early-trial-data/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/luveltamab-tazevibulin-showed-responses-in-platinum-resistant-ovarian-cancer-in-dose-optimization-data-the-trial-was-later-terminated/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/investigational-triple-negative-breast-cancer-vaccine-shows-safety-and-immune-response-in-phase-1-trial/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/six-year-olympia-data-sustain-the-adjuvant-olaparib-survival-benefit-in-brca-mutated-her2-negative-early-breast-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/ambassador-trial-finds-adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-bladder-cancer-not-yet-fda-approved-for-this-use/2026-08-13T23:43:24Zhttps://cancerdiscoveries.com/discoveries/fda-approves-blinatumomab-in-the-consolidation-phase-of-b-cell-precursor-acute-lymphoblastic-leukemia-regardless-of-mrd-status/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/personalized-neoantigen-vaccine-shows-no-cancer-recurrence-in-small-phase-1-kidney-cancer-trial/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-zolbetuximab-for-cldn18-2-positive-gastric-and-gastroesophageal-junction-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/adding-lenvatinib-and-pembrolizumab-to-tace-improves-progression-free-survival-in-liver-cancer-but-the-trials-overall-survival-goal-was-not-met/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-converts-tisotumab-vedotins-accelerated-approval-to-full-approval-for-recurrent-or-metastatic-cervical-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-tovorafenib-the-first-systemic-therapy-for-braf-altered-pediatric-low-grade-glioma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-talquetamab-a-first-in-class-bispecific-antibody-for-heavily-pretreated-multiple-myeloma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/landmark-nhs-galleri-multi-cancer-blood-test-trial-missed-its-primary-goal-but-found-real-gains-in-earlier-stage-detection/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/a-widely-shared-case-series-claiming-a-veterinary-dewormer-treats-cancer-was-retracted-for-an-undisclosed-conflict-of-interest-not-disproven-data/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/a-lab-made-molecular-glue-reprograms-a-lymphoma-oncogene-to-trigger-cancer-cell-self-destruction-in-early-cell-and-mouse-studies/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-lifileucel-the-first-tumor-derived-t-cell-therapy-for-advanced-melanoma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-eflornithine-the-first-therapy-to-reduce-relapse-risk-in-high-risk-pediatric-neuroblastoma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-epcoritamab-a-first-in-class-bispecific-antibody-for-relapsed-or-refractory-large-b-cell-lymphoma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-converts-tarlatamabs-accelerated-approval-to-full-approval-for-small-cell-lung-cancer-on-a-real-survival-benefit/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-perioperative-pembrolizumab-for-head-and-neck-cancer-the-first-approval-for-this-cancer-in-6-years/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-zanidatamab-for-her2-positive-biliary-tract-cancer-including-cholangiocarcinoma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-selpercatinib-the-first-targeted-therapy-for-young-children-with-ret-altered-thyroid-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/first-in-human-trial-tests-ultra-fast-flash-proton-radiotherapy-for-painful-bone-metastases/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/prospective-trial-finds-robotic-surgery-a-safe-option-for-right-sided-colon-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/national-mortality-data-show-a-substantial-drop-in-cervical-cancer-deaths-among-hpv-vaccinated-women-in-england/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/phase-3-ascent-07-trial-finds-no-progression-free-survival-benefit-for-sacituzumab-govitecan-over-chemotherapy-in-hr-positive-breast-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-clears-ai-powered-second-read-tool-that-catches-missed-prostate-cancers-on-biopsy/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-sotorasib-plus-panitumumab-the-first-kras-g12c-targeted-combination-for-colorectal-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-cologuard-plus-a-next-generation-stool-dna-test-for-colorectal-cancer-screening/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/personalized-mrna-cancer-vaccine-plus-pembrolizumab-reduces-melanoma-recurrence-risk-in-randomized-phase-2b-trial/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-the-first-ctdna-guided-adjuvant-immunotherapy-for-bladder-cancer-after-surgery/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-the-first-all-oral-combination-regimen-for-older-adults-with-newly-diagnosed-acute-myeloid-leukemia/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-optune-pax-a-wearable-electric-field-device-for-locally-advanced-pancreatic-cancer/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-the-first-immunotherapy-regimen-for-platinum-resistant-ovarian-cancer-with-a-proven-survival-benefit/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-approves-breyanzi-as-the-first-car-t-cell-therapy-for-marginal-zone-lymphoma/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/fda-grants-traditional-approval-to-pirtobrutinib-for-btk-inhibitor-pretreated-cll-sll/2026-08-13T23:43:25Zhttps://cancerdiscoveries.com/discoveries/trial-watch-testing-whether-hormone-therapy-with-ribociclib-is-as-effective-as-chemotherapy-followed-by-hormone-therapy-with-ribociclib-for-the-treatment-of-high-anatomic-stage-breast-cancer-with-low/2026-08-14T03:06:14Zhttps://cancerdiscoveries.com/discoveries/trial-watch-firmonertinib-versus-platinum-based-chemotherapy-as-first-line-treatment-for-nsclc-with-egfr-pacc-or-egfr-l861q-mutation/2026-08-14T03:06:14Z